Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images Danish pharmaceutical giant Novo Nordisk on Wednesday announced plans to cut around 9,000 roles, or roughly 11.5% of its global workforce. “Novo Nordisk today announced a company-wide transformation to simplify its organisation, improve the speed of decision-making, and reallocate resources …
Read More »Novo Has High Hopes That Ozempic Pill Can Also Fight Dementia Bloomberg.com Novo Nordisk Tests Ozempic for 20% Dementia Risk Reduction AInvest Novo Nordisk Tests Ozempic for 20% Lower Alzheimer’s Risk AInvest Source link
Read More »
Danish drugmaker Novo Nordisk (NVO), a top competitor to American pharmaceutical giant Eli Lilly (LLY), is currently exciting investors in Europe. The company’s stock price is up about 2% to $57.7 (DKK 365.35) as of 10:33 a.m. EDT on the Nasdaq Copenhagen Stock Exchange. On Germany’s Xetra, the shares also rose by 2.36% to $57 (EUR 48.94) as of 10:30 …
Read More »Novo Nordisk Says Wegovy Cuts Heart Risk by 57% Compared With Eli Lilly’s Obesity Drug – WSJ The Wall Street Journal Novo Nordisk’s Wegovy cuts heart risk by 57% versus rival Lilly weight-loss drug in study Reuters Wegovy trial result gives boost to Novo Nordisk amid U.S. market woes CNBC Novo’s Wegovy Beats Lilly’s Zepbound for Heart Health, Study Finds. What It Means …
Read More »Novo Nordisk’s Wegovy cuts heart risk by 57% versus rival Lilly weight-loss drug in study Reuters Weight loss drugs can halve heart patients’ risk of early death, study finds The Guardian Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease PR Newswire Weight loss jabs could …
Read More »
Novo Nordisk (NVO) stock was down on Tuesday, despite a lack of news from the pharmaceutical company. Instead, investors can turn to rival drug maker Eli Lilly (LLY) to learn why shares of NVO stock have fallen today. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights …
Read More »
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly‘s stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street. In a key late-stage trial, Eli Lilly’s pill, orforglipron, caused …
Read More »Drugmaker Novo Nordisk freezes hiring for non-critical jobs Reuters Novo Nordisk’s new CEO is said to start hiring freeze to cut costs (NVO:NYSE) Seeking Alpha Novo Nordisk’s New CEO Starts Hiring Freeze in Cost-Cutting Push Bloomberg.com Pharmalittle: We’re reading about a Novo hiring freeze, coverage for GLP-1 drugs, and much more statnews.com Novo Nordisk’s Human Capital Shift: A Calculated Bet on R&D Efficiency and …
Read More »
GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic Business Wire Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients CNBC GoodRx stock soars after striking deal to sell Novo Nordisk’s GLP-1s for $499/month Yahoo Finance Novo Nordisk halves US price of Ozempic Financial Times Novo Nordisk offers Ozempic at $499 per month to eligible …
Read More »Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers Reuters Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients CNBC GoodRx stock soars after striking deal to sell Novo Nordisk’s GLP-1s for $499/month Yahoo Finance Novo Nordisk halves US price of Ozempic Financial Times Novo Halves Ozempic Price to $499 a Month for …
Read More »